First in Human Study of T3P-Y058-739 (T3P)
Clinical trial NCT05120596 · RECRUITING
Trial details
- NCT number
- NCT05120596
- Sponsor
- T3 Pharmaceuticals AG
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2027-02-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.